Skip to main content

Advertisement

Log in

Development and validation of an LC-ESI-MS/MS method for the simultaneous quantification of naproxen and sumatriptan in human plasma: application to a pharmacokinetic study

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

A sensitive and fast liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) method was developed and validated for the simultaneous quantification of naproxen and sumatriptan in human plasma. A simple liquid-liquid extraction procedure, with a mixture of ethyl acetate, methyl tert-butyl ether, and dichloromethane (4:3:3, v/v), was used for the cleanup of plasma. Naratriptan and aceclofenac were employed as internal standards. The analyses were carried out using an ACE C18 column (50 × 4.6 mm i.d.; particle size 5 μm) and a mobile phase consisting of 2 mM aqueous ammonium acetate with 0.025 % formic acid and methanol (38:62, v/v). A triple-quadrupole mass spectrometer equipped with an electrospray source in the positive mode was set up in the selective reaction monitoring mode to detect the ion transitions m/z 231.67 → m/z 185.07, m/z 296.70 → m/z 157.30, m/z 354.80 → m/z 215.00, and m/z 336.80 → m/z 97.94 for naproxen, sumatriptan, aceclofenac, and naratriptan, respectively. The method was validated and proved to be linear, accurate, precise, and selective over the ranges of 2.5–130 μg mL−1 for naproxen and 1–50 ng mL−1 for sumatriptan. The validated method was successfully applied to a pharmacokinetic study with simultaneous administration of naproxen sodium and sumatriptan succinate tablet formulations in healthy volunteers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Tajti J, Szok D, Majláth Z, Tuka B, Csáti A, Vécsei L. Migraine and neuropeptides. Neuropept. 2015;52:19–30.

    Article  CAS  Google Scholar 

  2. International Headache Society. The international classification of headache disorders. Cephalalgia. 2004;24:160.

    Google Scholar 

  3. Olesen J, Burstein R, Ashina M, Tfelt-Hansen P. Origin of pain in migraine: evidence for peripheral sensitization. Lancet Neurol. 2009;8:679–90.

    Article  Google Scholar 

  4. Bartleson JD, Cutrer FM. Migraine update. Diagnosis and Treatment Minn Med. 2010;93:36–41.

    CAS  Google Scholar 

  5. Michael AM, Lotfy HM, Reda MR, Michail K, Somayaji V, Siraki AG, et al. Simultaneous determination of sumatriptan and naproxen in dosage forms and human plasma using LC/MS. Curr Anal Chem. 2012;8:512–9.

    Article  CAS  Google Scholar 

  6. Sheshala R, Khan N, Darwis Y. Validated high performance liquid chromatography (HPLC) method for the determination of sumatriptan in rabbit plasma: application to pharmacokinetic study. Afr J Pharm Pharmacol. 2012;6:98–107.

    CAS  Google Scholar 

  7. Gilart N, Marcé RM, Borrull F, Fontanals N. Determination of pharmaceuticals in wastewaters using solid-phase extraction-liquid chromatography-tandem mass spectrometry. J Sep Sci. 2012;35:875–82.

    Article  CAS  Google Scholar 

  8. Chang MS, Ji Q, Zhang J, El-Shourbagy TA. Historical review of sample preparation for chromatographic bioanalysis: pros and cons. Drug Dev Res. 2007;68:107–33.

    Article  CAS  Google Scholar 

  9. Farrar F, Letziga L, Gillbet M. Validation of a liquid chromatographic method for the determination of ibuprofen in human plasma. J Chromatogr B. 2002;780:341–8.

    Article  CAS  Google Scholar 

  10. Zaghloul AA, Hussain A, Khan MA, Ahsan F. Development of a HPLC method for the determination of cyclosporin-a in rat blood and plasma using naproxen as an internal standard. J Pharm Biomed Anal. 2003;31:1101–7.

    Article  CAS  Google Scholar 

  11. Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, et al. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Clin Ther. 2009;31:399–410.

    Article  CAS  Google Scholar 

  12. Nasir F, Iqbal Z, Khan A, Ahmad L, Shah Y, Khan AZ, et al. Simultaneous determination of timolol maleate, rosuvastatin calcium and diclofenac sodium in pharmaceuticals and physiological fluids using HPLC-UV. J Chromatogr B. 2011;879:3434–43.

    Article  CAS  Google Scholar 

  13. Shah Y, Iqbal Z, Ahmad L, Khan A, Khan MI, Nazir S, et al. Simultaneous determination of rosuvastatin and atorvastatin in human serum using RP-HPLC/UV detection: method development, validation and optimization of various experimental parameters. J Chromatogr B. 2011;879:557–63.

    Article  CAS  Google Scholar 

  14. Ge Z, Tessier E, Neirinck L, Zhu Z. High performance liquid chromatographic method for the determination of sumatriptan with fluorescence detection in human plasma. J Chromatogr B. 2004;806:299–303.

    Article  CAS  Google Scholar 

  15. Zhang H, Jiang Y, Wen J, Zhou T, Fan G, Wu Y. Rapid determination of telmisartan in human plasma by HPLC using a monolithic column with fluorescence detection and its application to a bioequivalence study. J Chromatogr B. 2009;877:3729–33.

    Article  CAS  Google Scholar 

  16. Chmielewska A, Konieczna L, Plenis A, Bieniecki M, Lamparczyk H. Determination of diclofenac in plasma by high-performance liquid chromatography with electrochemical detection. Biomed Chromatogr. 2006;20:119–24.

    Article  CAS  Google Scholar 

  17. Khan A, Khan MI, Iqbal Z, Ahmad L, Shah Y, Watson DG. Determination of lipoic acid in human plasma by HPLC-ECD using liquid–liquid and solid-phase extraction: method development, validation and optimization of experimental parameters. J Chromatogr B. 2010;878:2782–8.

    Article  CAS  Google Scholar 

  18. Khan A, Iqbal Z, Watson DG, Khan A, Khan I, Muhammad N, et al. Simultaneous determination of lipoic acid (LA) and dihydrolipoic acid (DHLA) in human plasma using high-performance liquid chromatography coupled with electrochemical detection. J Chromatogr B. 2011;879:1725–31.

    Article  CAS  Google Scholar 

  19. Duléry BD, Petty MA, Schoun J, David M, Huebert ND. A method using a liquid chromatographic-electrospray-mass spectrometric assay for the determination of antimigraine compounds: preliminary pharmacokinetics of MDL 74,721, sumatriptan and naratriptan, in rabbit. J Pharm Biomed Anal. 1997;15:1009–20.

    Article  Google Scholar 

  20. Cheng KN, Redrup MJ, Barrow A, Williams PN. Validation of a liquid chromatographic tandem mass spectrometric method for the determination of sumatriptan in human biological fluids. J Pharm Biomed Anal. 1998;17:399–408.

    Article  CAS  Google Scholar 

  21. Chen J, Jiang W, Cai J, Tao W, Gao X, Jiang X. Quantification of lipoic acid in plasma by high-performance liquid chromatography–electrospray ionization mass spectrometry. J Chromatogr B. 2005;824:249–57.

    Article  CAS  Google Scholar 

  22. Chen X, Liu D, Luan Y, Jin F, Zhong D. Determination of zolmitriptan in human plasma by liquid chromatography–tandem mass spectrometry method: application to a pharmacokinetic study. J Chromatogr B. 2006;832:30–5.

    Article  CAS  Google Scholar 

  23. Tan A, Hang P, Couture J, Hussain S, Vallée F. An evaporation-free solid-phase extraction method for rapid and accurate analysis of sumatriptan in human plasma by LC–MS/MS. J Chromatogr B. 2007;856:9–14.

    Article  CAS  Google Scholar 

  24. Elsinghorst PW, Kinzig M, Rodamer M, Holzgrabe U, Sörgel F. An LC-MS/MS procedure for the quantification of naproxen in human plasma: development, validation, comparison with other methods, and application to a pharmacokinetic study. J Chromatogr B. 2011;879:1686–96.

    Article  CAS  Google Scholar 

  25. Sørensen LK. Determination of acidic and neutral therapeutic drugs in human blood by liquid chromatography–electrospray tandem mass spectrometry. Forensic Sci Int. 2011;206:119–26.

    Article  Google Scholar 

  26. Yadav M, Patel C, Patel M, Mishra T, Baxi GA, Singhal P, et al. Development and validation of a sensitive and rapid method to determine naratriptan in human plasma by LC-ESI-MS/MS: application to a bioequivalence study. J Chromatogr Sci. 2011;49:101–7.

    Article  CAS  Google Scholar 

  27. Rao RN, Guruprasad K, Gangu Naidu C, Raju B, Srinivas R. LC–ESI-MS/MS determination of in vivo metabolites of almotriptan in rat plasma, urine and feces: application to pharmacokinetics. J Chromatogr B. 2012;891-892:44–51.

    Article  Google Scholar 

  28. Berges A, Walls C, Lener SE, Mcdonald SA. Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: a randomized, open-label, three-period crossover study in healthy volunteers. Clin Ther. 2010;32:1165–77.

    Article  CAS  Google Scholar 

  29. Haberer LJ, Walls CM, Lener SE, Taylor DR, Mcdonald SA. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine. Headache. 2010;50:357–73.

    Article  Google Scholar 

  30. Patel DP, Sharma P, Sanyal M, Singhal P, Shrivastav PS. Challenges in the simultaneous quantitation of sumatriptan and naproxen in human plasma: application to a bioequivalence study. J Chromatogr B. 2012;902:122–31.

    Article  CAS  Google Scholar 

  31. ANVISA. RDC 27, Validação De Métodos Bioanalíticos, 2012.

  32. EMA. Guideline on bioanalytical method validation, 2011.

  33. FDA. Guidance for industry. Bioanalytical method validation, 2013.

  34. INMETRO. Orientação sobre validação de métodos de ensaios químicos (Guidelines for the validation of chemical testing methods), Doq-Cgcre-008 Rev. 02, 2007. 25.

  35. INMETRO, Orientação sobre validação de métodos analíticos (Guidelines for the validation of analytical methods), Doq-Cgcre-008 Rev. 04, 2011, P. 20.

  36. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem. 2005;38:328–34.

    Article  CAS  Google Scholar 

  37. Loffler D, Ternes TA. Determination of acidic pharmaceuticals, antibiotics and ivermectin in river sediment using liquid chromatography–tandem mass spectrometry. J Chromatogr A. 2003;1021:133–44.

    Article  Google Scholar 

Download references

Acknowledgments

The authors acknowledge Pró-Reitoria de Pesquisa at the UFMG for providing funds for publication and the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for providing scholarship and funds for research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Isabela Costa César.

Ethics declarations

Written consent was obtained from all of the volunteers after informing them about the objectives and possible risks involved in the study. The study protocol was approved by the Ethics Committee of the Instituto de Ciências Farmacêuticas.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brêtas, J.M., César, I.C., Brêtas, C.M. et al. Development and validation of an LC-ESI-MS/MS method for the simultaneous quantification of naproxen and sumatriptan in human plasma: application to a pharmacokinetic study. Anal Bioanal Chem 408, 3981–3992 (2016). https://doi.org/10.1007/s00216-016-9488-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-016-9488-x

Keywords

Navigation